347 related articles for article (PubMed ID: 28982336)
1. Multi-Target Metal-Based Anticancer Agents.
Chen ZF; Orvig C; Liang H
Curr Top Med Chem; 2017 Nov; 17(28):3131-3145. PubMed ID: 28982336
[TBL] [Abstract][Full Text] [Related]
2. Multi-Targeted Anticancer Agents.
Zheng W; Zhao Y; Luo Q; Zhang Y; Wu K; Wang F
Curr Top Med Chem; 2017 Nov; 17(28):3084-3098. PubMed ID: 28685693
[TBL] [Abstract][Full Text] [Related]
3.
A Patil S; P Hoagland A; A Patil S; Bugarin A
Future Med Chem; 2020 Dec; 12(24):2239-2275. PubMed ID: 33228391
[No Abstract] [Full Text] [Related]
4. New manganese(II), iron(II), cobalt(II), nickel(II) and copper(II) saccharinate complexes of 2,6-bis(2-benzimidazolyl)pyridine as potential anticancer agents.
Icsel C; Yilmaz VT; Aydinlik Ş; Aygun M
Eur J Med Chem; 2020 Sep; 202():112535. PubMed ID: 32653697
[TBL] [Abstract][Full Text] [Related]
5. Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models.
Kacsir I; Sipos A; Bényei A; Janka E; Buglyó P; Somsák L; Bai P; Bokor É
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054999
[TBL] [Abstract][Full Text] [Related]
6. The Effects on Angiogenesis of Relevant Inorganic Chemotherapeutics.
Marzo T; La Mendola D
Curr Top Med Chem; 2021; 21(1):73-86. PubMed ID: 33243124
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of histone deacetylases, topoisomerases and epidermal growth factor receptor by metal-based anticancer agents: Design & synthetic strategies and their medicinal attributes.
Kaur M; Loveleen ; Kumar R
Bioorg Chem; 2020 Dec; 105():104396. PubMed ID: 33130345
[TBL] [Abstract][Full Text] [Related]
8. Copper, gold and silver compounds as potential new anti-tumor metallodrugs.
Tan SJ; Yan YK; Lee PP; Lim KH
Future Med Chem; 2010 Oct; 2(10):1591-608. PubMed ID: 21426151
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of tridentate pincer and related metal complexes.
Wu S; Wu Z; Ge Q; Zheng X; Yang Z
Org Biomol Chem; 2021 Jun; 19(24):5254-5273. PubMed ID: 34059868
[TBL] [Abstract][Full Text] [Related]
10. Looking Beyond DNA as the Target of Inorganic Chemotherapy Agents: The Key Role of Protein Metalation and Metal Homeostasis.
Marzo T; Mendola D
Curr Top Med Chem; 2021; 21(1):3-5. PubMed ID: 33443001
[No Abstract] [Full Text] [Related]
11. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Lazarević T; Rilak A; Bugarčić ŽD
Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
[TBL] [Abstract][Full Text] [Related]
12. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
Banerjee S; Chakravarty AR
Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
[TBL] [Abstract][Full Text] [Related]
13. Recent progress and future potential for metal complexes as anticancer drugs targeting G-quadruplex DNA.
Zhang J; Zhang F; Li H; Liu C; Xia J; Ma L; Chu W; Zhang Z; Chen C; Li S; Wang S
Curr Med Chem; 2012; 19(18):2957-75. PubMed ID: 22519400
[TBL] [Abstract][Full Text] [Related]
14. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
[TBL] [Abstract][Full Text] [Related]
15. Combining Inorganic Chemistry and Biology: The Underestimated Potential of Metal Complexes in Medicine.
Karges J
Chembiochem; 2020 Nov; 21(21):3044-3046. PubMed ID: 32896976
[TBL] [Abstract][Full Text] [Related]
16. Anticancer metallodrugs: where is the next cisplatin?
Hanif M; Hartinger CG
Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
[TBL] [Abstract][Full Text] [Related]
17. Recent development of transition metal complexes with in vivo antitumor activity.
Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
[TBL] [Abstract][Full Text] [Related]
19. New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent.
Guerriero A; Oberhauser W; Riedel T; Peruzzini M; Dyson PJ; Gonsalvi L
Inorg Chem; 2017 May; 56(10):5514-5518. PubMed ID: 28443659
[TBL] [Abstract][Full Text] [Related]
20. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
Notaro A; Gasser G
Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
